530 results on '"Maksymowych W"'
Search Results
2. LBA0003 MINIMAL SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS OVER 2 YEARS OF BIMEKIZUMAB TREATMENT: RESULTS FROM A PHASE 3 OPEN-LABEL EXTENSION STUDY
3. POS0806 LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
4. POS0050 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR DATA FROM THE PHASE 3 SELECT-AXIS 2 STUDY
5. POS1094 AUTOANTIBODIES TO 14-3-3Η IN AXIAL SPONDYLOARTHRITIS
6. POS0038 ANATOMICAL DISTRIBUTION OF MRI LESIONS IN axSpA AND DIFFERENCES BETWEEN PATIENTS WITH AND WITHOUT PERIPHERAL INVOLVEMENT: RESULTS FROM THE ASAS CLASSIFICATION COHORT
7. POS0058 IMPACT OF BIMEKIZUMAB ON MRI INFLAMMATORY AND STRUCTURAL LESIONS IN THE SACROILIAC JOINTS OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS AND POST HOC ANALYSES FROM THE BE MOBILE 1 AND 2 PHASE 3 STUDIES
8. POS0798 EFFICACY, SAFETY AND RADIOGRAPHIC OUTCOMES FROM THE PHASE 3 SELECT-AXIS 2 STUDY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND AN INADEQUATE RESPONSE TO BIOLOGIC DMARD THERAPY: 2-YEAR DATA
9. POS0246 BIMEKIZUMAB REDUCED MRI INFLAMMATORY LESIONS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: WEEK 52 RESULTS FROM THE BE MOBILE 1 AND BE MOBILE 2 PHASE 3 STUDIES
10. AB0198 THRESHOLDS OF PRESENTEEISM MEASUREMENT INSTRUMENTS FOR UNACCEPTABLE WORK PARTICIPATION AND FUTURE ADVERSE WORK OUTCOMES IN RA
11. POS0226 APREMILAST REDUCES INFLAMMATION AS MEASURED BY MRI OF THE HAND IN PATIENTS WITH PSORIATIC ARTHRITIS: PRIMARY RESULTS FROM THE PHASE 4 MOSAIC STUDY
12. POS0918 VALIDATION OF A MODIFIED NEW YORK CRITERIA RETIC E-TOOL FOR INCREASING SCORING PROFICIENCY OF RADIOGRAPHS OF THE SACROILIAC JOINTS IN AXIAL SPONDYLOARTHRITIS
13. POS1109 PUTATIVE ROLE OF THE HISTIDINE AND TRYPTOPHAN BIOCHEMICAL PATHWAYS IN THE MODE OF ACTION OF UPADACITINIB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
14. POS0250 PLACEBO-CONTROLLED EFFICACY AND SAFETY OF UPADACITINIB THROUGH ONE YEAR IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
15. POS1111 TREATMENT WITH UPADACITINIB RESULTS IN THE INHIBITION OF A BROAD RANGE OF POTENTIALLY PATHOGENIC PATHWAYS IN NR-AXSPA AND BDMARD-IR AS PATIENTS: PROTEOMIC ANALYSIS FROM THE SELECT-AXIS 2 PHASE 3 STUDIES
16. AB1535 EFFICACY OF APREMILAST ON WHOLE-BODY INFLAMMATION INDICES IN PATIENTS WITH PSORIATIC ARTHRITIS: ASSESSMENTS BY WHOLE-BODY MAGNETIC RESONANCE IMAGING IN THE PHASE 4 MOSAIC STUDY
17. POS0664 DEFINING THRESHOLDS OF PRESENTEEISM MEASURES FOR UNACCEPTABLE WORK PARTICIPATION IN AxSpA
18. AB0409 TIME TO FIRST REMISSION AND PREVALENCE OF SUSTAINED REMISSION AFTER ETANERCEPT BIOSIMILAR (ETA-B) OR ORIGINATOR (ETA-O) INITIATION IN RHEUMATOID ARTHRITIS (RA)
19. POS1103 BIMEKIZUMAB MAINTAINED IMPROVEMENTS IN EFFICACY ENDPOINTS AND HAD A CONSISTENT SAFETY PROFILE THROUGH 52 WEEKS IN PATIENTS WITH NON-RADIOGRAPHIC AND RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PARALLEL PHASE 3 STUDIES
20. Peripartum issues in the inflammatory arthritis patient: A survey of the RAPPORT registry
21. Efficacité d’upadacitinib chez des patients atteints de spondyloarthrite axiale non radiographique en fonction des signes objectifs d’inflammation à l’inclusion
22. Amélioration des signes et symptômes chez les patients atteints de spondyloathrite axiale non radiographique traités par le bimékizumab : résultats à 24 semaines d’une étude de phase III
23. Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part II: Structural damage lesions
24. OP0152 A DEEP LEARNING FRAMEWORK FOR MRI DETECTION OF ACTIVE INFLAMMATORY AND STRUCTURAL CHANGES IN THE SACROILIAC JOINT CONSISTENT WITH AXIAL SPONDYLOARTHRITIS: AN INTERNATIONAL COLLABORATIVE STUDY
25. POS0995 VALIDATION OF THE SPARCC MRI-RETIC E-TOOL FOR INCREASING SCORING PROFICIENCY OF MRI LESIONS IN AXIAL SPONDYLOARTHRITIS
26. OP0216 DEVELOPMENT, REFINEMENT AND WEIGHTING OF CANDIDATE CRITERIA FOR AXIAL DISEASE IN JUVENILE SPONDYLOARTHRITIS: AN INTERNATIONAL COLLABORATION
27. OP0016 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
28. POS0111 MORE METICULOUSLY FOLLOWING TREAT-TO-TARGET IN RA DOES NOT LEAD TO LESS RADIOGRAPHIC PROGRESSION: A LONGITUDINAL ANALYSIS IN BIODAM
29. POS0153 MRI SPINAL LESIONS IN PATIENTS WITHOUT MRI OR RADIOGRAPHIC LESIONS IN THE SACROILIAC JOINTS TYPICAL OF AXIAL SPONDYLOARTHRITIS
30. POS0173 DATA-DRIVEN MRI DEFINITIONS FOR ACTIVE AND STRUCTURAL SACROILIAC JOINT LESIONS IN JUVENILE SPONDYLOARTHRITIS TYPICAL OF AXIAL DISEASE
31. POS0341 CONSENSUS-DRIVEN DEFINITION FOR UNEQUIVOCAL SACROILIITIS ON RADIOGRAPHS IN JUVENILE SPONDYLOARTHRITIS
32. POS1258 LESS THAN EXPECTED IMPACT OF RHEUMATOID ARTHRITIS AND AXIAL SPONDYLOARTHRITIS DISEASE ON COVID SEVERITY
33. POS1259 AXIAL SPONDYLOARTHRITIS, AGE AND MALE GENDER IMPACT COVID VACCINATION AEs MORE THAN RHEUMATOID ARTHRITIS
34. OP0150 ASAS RECOMMENDATIONS FOR REQUESTING AND REPORTING IMAGING EXAMINATIONS IN PATIENTS WITH SUSPECTED AXIAL SPONDYLOARTHRITIS
35. POS0941 LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON‑RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
36. OP0229 OSTEOARTHRITIS OF THE KNEE, INFLAMMATION, AND THE EFFECT OF ADALIMUMAB (OKINADA): A RANDOMIZED PLACEBO-CONTROLLED TRIAL
37. POS0989 DEVELOPMENT OF INTERNATIONAL CONSENSUS ON A STANDARDIZED IMAGE ACQUISITION PROTOCOL FOR DIAGNOSTIC EVALUATION OF THE SACROILIAC JOINTS BY MRI – AN ASAS-SPARTAN COLLABORATION.
38. POS0939 BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO‑CONTROLLED STUDY
39. POS0301 STRUCTURAL OUTCOMES IN THE SACROILIAC JOINT AFTER IXEKIZUMAB TREATMENT FOR 16 WEEKS IN PATIENTS WITH ACTIVE NON‑RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY GENDER, HLA-B27, AND BASELINE MRI INFLAMMATION
40. BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY
41. LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS
42. Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis
43. Efficacité et tolérance d’upadacitinib chez des patients atteints de spondylarthrite ankylosante active : résultats à 2 ans d’une étude randomisée, en double aveugle, contrôlée versus placebo avec extension en ouvert
44. Facteurs prédictifs de la réponse chez les patients atteints de spondyloarthrite axiale non radiographique recevant le certolizumab pegol dans l’étude C-axSpAnd
45. Diagnostic utility of IBP criteria in an inception cohort of patients with psoriasis, iritis, or colitis presenting with undiagnosed back pain
46. Performance of three referral algorithms for diagnosing axial spondyloarthritis
47. PE.Lu-136 - Performance de la TEP au fluorure de sodium 18 comparée à l’IRM pour l’évaluation des anomalies sacro-iliaque inflammatoires et structurales dans une population de spondyloarthrites axiales
48. PE.Lu-050 - Le certolizumab pegol dans le traitement de la spondyloarthrite axiale : résultats à 4 ans de l’étude RAPID-axSpA
49. PE.Lu-021 - Quelle est la validité du concept de poussée rapportée par le patient dans la spondylarthrite ankylosante et quelle était la fréquence de ces poussées avant l’ère des anti-TNF ? Analyse transversale de 234 patients
50. P.09 - Performance de la TEP au fluorure de sodium 18 pour couplée au scanner pour l’évaluation des sacro-iliites inflammatoire et structurales comparée à l’IRM et au scanner dans les spondyloarthrites axiales
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.